electroCore (ECOR) Income towards Parent Company (2017 - 2026)
electroCore's (ECOR) quarterly Income towards Parent Company came in at -$5.3 million in Q1 2026, down 36.73% year-on-year from -$8.3 million in Q1 2025, and down 149.31% quarter-over-quarter from $10.7 million in Q4 2025.
electroCore (ECOR) Income towards Parent Company (2017 - 2026) Analysis & Trends
electroCore's Income towards Parent Company history runs 10 years deep, the most recent figure standing at -$5.3 million for Q1 2026.
- On a quarterly basis, Income towards Parent Company fell 36.73% year-over-year to -$5.3 million in Q1 2026; TTM through Mar 2026 was -$1.7 million, a 85.7% increase from a year earlier, with the FY2025 full-year figure at -$242000.0, up 97.85% from the prior year.
- Income towards Parent Company eased to -$5.3 million in Q1 2026 per ECOR's latest filing, from $10.7 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at $10.7 million in Q4 2025 and bottomed at -$5.9 million in Q1 2023.
- The 5-year median for Income towards Parent Company is -$3.9 million (2025), against an average of -$3.4 million.
- Across the five-year window, Income towards Parent Company sank 149.35% in 2022 and soared 513.18% in 2025, its largest moves.
- Year by year, Income towards Parent Company stood at -$5.8 million in 2022, then jumped by 35.66% to -$3.7 million in 2023, then soared by 30.55% to -$2.6 million in 2024, then surged by 513.18% to $10.7 million in 2025, then plunged by 149.31% to -$5.3 million in 2026.
- Per Business Quant, the three latest ECOR Income towards Parent Company figures stand at -$5.3 million (Q1 2026), $10.7 million (Q4 2025), and -$3.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | electroCore | 55,642.90 | -8.77 Mn | 8.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.27 Mn |
| Dec 31, 2025 | 10.69 Mn |
| Sep 30, 2025 | -3.41 Mn |
| Jun 30, 2025 | -3.67 Mn |
| Mar 31, 2025 | -3.86 Mn |
| Dec 31, 2024 | -2.59 Mn |
| Sep 30, 2024 | -2.50 Mn |
| Jun 30, 2024 | -2.66 Mn |
| Mar 31, 2024 | -3.51 Mn |
| Dec 31, 2023 | -3.73 Mn |
| Sep 30, 2023 | -4.03 Mn |
| Jun 30, 2023 | -4.90 Mn |
| Mar 31, 2023 | -5.87 Mn |
| Dec 31, 2022 | -5.79 Mn |
| Sep 30, 2022 | -5.45 Mn |
| Jun 30, 2022 | -5.34 Mn |
| Mar 31, 2022 | -5.58 Mn |
| Dec 31, 2021 | 11.73 Mn |
| Sep 30, 2021 | -3.99 Mn |
| Jun 30, 2021 | -2.89 Mn |